Neupogen Trademark Details

Neupogen was registered on Tuesday, May 22, 1990 and is currently owned by Amgen Inc. under the registration number 1597117 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 14 years ago on Monday, May 3, 2010, according to the United State Patent & Trademark Office
Word Mark Neupogen
Status Alive Registered 800 — Registered and Renewed

Current Owner

Amgen Inc. of Newbury Park, CA

View all trademarks for Amgen Inc.
Other Trademarks for Amgen Inc.
Serial Number 73820719
Registration Number 1597117
Status Date Monday, May 3, 2010
Filing Date Monday, May 3, 2010
Registration Date Tuesday, May 22, 1990
Attorney Mark I. Feldman, Christina L. Martini

Correspondent

Mark I. Feldman, Christina L. Martini
DLA Piper LLP (US)
P.O. BOX 64807
CHICAGO IL 60664-0807

Case File Statements

Certificate of Correction for Registration In the Statement, Column 1, Line 7, "Protection" Should Be Deleted and "Production" Should Be Inserted.
Goods & Services Pharmaceutical Preparations - Namely, Recombinant-Human Granulocyte-Csf for Use in Stimulating White Blood Cell [ Protection ] * Production *

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 6 — Active
Status Date Tuesday, September 12, 1989
First Use Anywhere Friday, August 12, 1988
First Use In Commerce Friday, August 12, 1988
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.